CANbridge Pharmaceuticals Inc. (01228.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 9Sep 14Sep 18

Key dataSep 18, 2026

OpenHKD 1.90

From 52W high−36.35%

Volume299000.00

Market capHKD 909.41M

P/E (TTM)—

P/S (TTM)14.0x

Div yield—

Key dataSep 18, 2026

Open

HKD 1.90

From 52W high

−36.35%

Volume

299000.00

Market cap

HKD 909.41M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.2x

P/E (TTM)

—

RSI (14)

53.6

MomentumView details →

1D Return

+4.97%

YTD Return

−21.68%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−8.2x

EV/Sales

12.9x

P/S (TTM)

14.0x

P/B (TTM)

−4.0x

ProfitabilityView details →

Gross Margin

71.47%

Net Margin

−146.41%

EBITDA Margin

−156.73%

ROE (TTM)

41.60%

ROA (TTM)

−42.37%

Asset Turnover

0.29x

GrowthView details →

Revenue YoY

−11.00%

EPS YoY

+50.78%

FCF YoY

−27.66%

Revenue CAGR 3Y

−14.14%

EPS CAGR 3Y

+102.88%

EBITDA YoY

+41.89%

MomentumView details →

1D Return

+4.97%

YTD Return

−21.68%

1Y Return

−21.06%

RSI (14)

53.6

vs 50D SMA

−0.41%

vs 200D SMA

−11.63%

Capital & dividendView details →

Debt/Equity

−0.15x

Current Ratio

0.43x

Quick Ratio

0.36x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

55.67M

Net Income (TTM)

−81.51M

Op. CF (TTM)

−29.39M

Next earningsApr 1, 2027 →

Latest newsMore news →

Canbridge Pharmaceuticals has initiated the registration process and commercialization preparations for its drug Velafermin β in key North African markets.52d ago

Similar companies

Lexicon Pharmaceuticals, Inc.LXRX JW (Cayman) Therapeutics Co. Ltd02126.HK Cybin Inc. Common StockHELP Immix Biopharma, Inc.IMMX Inventiva S.A.IVA Faeth Therapeutics, Inc.FTH Find similar companies →

Latest newsMore news →

Canbridge Pharmaceuticals has initiated the registration process and commercialization preparations for its drug Velafermin β in key North African markets.52d ago